|
Volumn 31, Issue 4, 2006, Pages 251-261
|
Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOLINE DERIVATIVE;
LUTEINIZING HORMONE;
NITRIC OXIDE;
PROLACTIN;
PROSTAGLANDIN E1;
TADALAFIL;
TESTOSTERONE;
VASODILATOR AGENT;
AGED;
ARTERY;
ARTICLE;
ATTITUDE TO HEALTH;
BLOOD;
BLOOD FLOW VELOCITY;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC ANGIOPATHY;
DRUG ADMINISTRATION;
DRUG EFFECT;
HUMAN;
IMPOTENCE;
INJECTION;
MALE;
METABOLISM;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
PENIS;
PSYCHOLOGICAL ASPECT;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VASCULARIZATION;
AGED;
ALPROSTADIL;
ARTERIES;
ATTITUDE TO HEALTH;
BLOOD FLOW VELOCITY;
CARBOLINES;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
IMPOTENCE;
INJECTIONS;
LUTEINIZING HORMONE;
MALE;
MIDDLE AGED;
NITRIC OXIDE;
PENIS;
PROLACTIN;
QUESTIONNAIRES;
TESTOSTERONE;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
|
EID: 34249659396
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|